OrbiMed Advisors LLC's Form 4 filing
Disc Medicine, Inc. (IRON) · filed Mar 12, 2025
- Accession no.
- 0000947871-25-000308
- Filed
- Mar 12, 2025, 9:34 PM ET
- Trade date
- Mar 10-12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 15 non-derivative transactions. Open-market sales total $17.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director |
| OrbiMed Capital GP VI LLCCIK 0001682115 | Director |
| OrbiMed Genesis GP LLCCIK 0001808744 | Director |
| OrbiMed Capital GP VIII LLCCIK 0001845804 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | Common Stock | SSaleDisposed | −68,766 | $54.29F1 | −$3,733,306.14 | 539,845 | Indirect | Duplicate filing |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −106,384 | $54.29F1 | −$5,775,587.36 | 835,185 | Indirect | Duplicate filing |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −26,596 | $54.29F1 | −$1,443,896.84 | 208,795 | Indirect | Duplicate filing |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −136 | $55.01F2 | −$7,481.36 | 539,709 | Indirect | Duplicate filing |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −211 | $55.01F2 | −$11,607.11 | 834,974 | Indirect | Duplicate filing |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −53 | $55.01F2 | −$2,915.53 | 208,742 | Indirect | Duplicate filing |
| Mar 11, 2025 | Common Stock | SSaleDisposed | −9,222 | $54.01F3 | −$498,080.22 | 530,487 | Indirect | Duplicate filing |
| Mar 11, 2025 | Common Stock | SSaleDisposed | −14,267 | $54.01F3 | −$770,560.67 | 820,707 | Indirect | Duplicate filing |
| Mar 11, 2025 | Common Stock | SSaleDisposed | −3,567 | $54.01F3 | −$192,653.67 | 205,175 | Indirect | Duplicate filing |
| Mar 12, 2025 | Common Stock | SSaleDisposed | −603 | $55.05F4 | −$33,195.15 | 529,884 | Indirect | Duplicate filing |
| Mar 12, 2025 | Common Stock | SSaleDisposed | −933 | $55.05F4 | −$51,361.65 | 819,774 | Indirect | Duplicate filing |
| Mar 12, 2025 | Common Stock | SSaleDisposed | −233 | $55.05F4 | −$12,826.65 | 204,942 | Indirect | Duplicate filing |
| Mar 12, 2025 | Common Stock | SSaleDisposed | −27,750 | $54.44F5 | −$1,510,710 | 502,134 | Indirect | Duplicate filing |
| Mar 12, 2025 | Common Stock | SSaleDisposed | −42,930 | $54.44F5 | −$2,337,109.2 | 776,844 | Indirect | Duplicate filing |
| Mar 12, 2025 | Common Stock | SSaleDisposed | −10,733 | $54.44F5 | −$584,304.52 | 194,209 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average purchase price of the shares of the Issuer's common stock purchased, ranging from a low of $54.00 to a high of $54.66 per share. The Reporting Persons undertake, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 3 transactions in Table I.
- F2
Represents the weighted average purchase price of the shares of the Issuer's common stock purchased, ranging from a low of $55.01 to a high of $55.02 per share. The Reporting Persons undertake, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 3 transactions in Table I.
- F3
Represents the weighted average purchase price of the shares of the Issuer's common stock purchased, ranging from a low of $54.00 to a high of $54.07 per share. The Reporting Persons undertake, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 3 transactions in Table I.
- F4
Represents the weighted average purchase price of the shares of the Issuer's common stock purchased, ranging from a low of $55.03 to a high of $55.11 per share. The Reporting Persons undertake, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 3 transactions in Table I.
- F5
Represents the weighted average purchase price of the shares of the Issuer's common stock purchased, ranging from a low of $54.00 to a high of $54.96 per share. The Reporting Persons undertake, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 3 transactions in Table I.